HUTCHMED (China) Limited (LON:HCM – Get Free Report)’s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 236.78 ($2.91) and traded as high as GBX 310 ($3.81). HUTCHMED shares last traded at GBX 305 ($3.75), with a volume of 53,531 shares trading hands.
HUTCHMED Stock Up 5.1 %
The company has a current ratio of 3.20, a quick ratio of 2.97 and a debt-to-equity ratio of 5.02. The stock’s 50-day moving average is GBX 281.64 and its 200-day moving average is GBX 237. The company has a market cap of £2.58 billion, a price-to-earnings ratio of -7,050.00 and a beta of 0.82.
HUTCHMED Company Profile
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for CRC, breast cancer, GC, endometrial cancer (EMC), NSCLC, hepatocellular carcinoma, and gastrointestinal and solid tumors.
- Five stocks we like better than HUTCHMED
- Investing in the High PE Growth Stocks
- 3 large caps with red hot RSIs with upside
- What Is WallStreetBets and What Stocks Are They Targeting?
- Johnson Controls International: Nothing but upside for investors
- What Are Dividend Challengers?
- Unity Software’s resilient rebound post-earnings setback
Receive News & Ratings for HUTCHMED Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HUTCHMED and related companies with MarketBeat.com's FREE daily email newsletter.